Mark L. Baum - Jul 18, 2023 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Signature
/s/ Mark L. Baum
Stock symbol
HROW
Transactions as of
Jul 18, 2023
Transactions value $
-$5,468,417
Form type
4
Date filed
7/20/2023, 07:48 PM
Previous filing
Apr 4, 2023
Next filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HROW Common Stock Options Exercise +762K +49.27% 2.31M Jul 18, 2023 Direct F1
transaction HROW Common Stock Tax liability -$5.47M -300K -12.99% $18.23 2.01M Jul 18, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HROW Performance Stock Unit Options Exercise $0 -762K -100% $0.00* 0 Jul 18, 2023 Common Stock 762K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 762,300 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 299,968 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan.